John Hussman13F | |
| Hussman Strategic Advisors, inc | |
| Last update 2026-05-12 | 268 Stocks (97 new) |
| Value $463.00 Mil | Turnover 48 % |
John Hussman Profile
Dr. John Hussman is the president and principal shareholder of Hussman Strategic Advisors, the investment advisory firm that manages the Hussman Funds. He is also the president of the Hussman Investment Trust. Dr. Hussman manages the Hussman Strategic Growth Fund, which invests primarily in U.S. stocks, and the Hussman Strategic Total Return Fund, which invests primarily in U.S. Treasury and government agency securities.
Prior to managing the Hussman Funds, Dr. Hussman was a professor of economics and international finance at the University of Michigan. His academic research centers on market efficiency and information economics. Dr. Hussman holds a Ph.D. in economics from Stanford University (1992) and two degrees from Northwestern University: a Master's degree in education and social policy (1985) and a Bachelor's degree in economics (1983).
Prior to managing the Hussman Funds, Dr. Hussman was a professor of economics and international finance at the University of Michigan. His academic research centers on market efficiency and information economics. Dr. Hussman holds a Ph.D. in economics from Stanford University (1992) and two degrees from Northwestern University: a Master's degree in education and social policy (1985) and a Bachelor's degree in economics (1983).
John Hussman Investing Philosophy
Dr. Hussman looks at two dimensions of information to adjust his willingness to take risk.
The first is valuation. Favorable valuation means that stock prices appear reasonable in view of the stream of earnings, dividends, revenues and cash flows expected in the future.
The second dimension is the quality of market action. Market action considers the behavior of a wide range of securities and industry groups in an attempt to assess the economic outlook of investors and their willingness to accept market risk.
These two dimensions of information make up four basic "Market Climates" associated with various combinations of valuation and market action. In the most favorable Market Climates, Dr. Hussman will typically hold an aggressive allocation to market risk, while in the least favorable Market Climates, he will typically attempt to remove the impact of market fluctuations from the portfolio through hedging (Strategic Growth Fund) or reduction in the average maturity of bond holdings (Strategic Total Return Fund). The most defensive position is a fully hedged position in which the entire value of long positions is hedged.
The first is valuation. Favorable valuation means that stock prices appear reasonable in view of the stream of earnings, dividends, revenues and cash flows expected in the future.
The second dimension is the quality of market action. Market action considers the behavior of a wide range of securities and industry groups in an attempt to assess the economic outlook of investors and their willingness to accept market risk.
These two dimensions of information make up four basic "Market Climates" associated with various combinations of valuation and market action. In the most favorable Market Climates, Dr. Hussman will typically hold an aggressive allocation to market risk, while in the least favorable Market Climates, he will typically attempt to remove the impact of market fluctuations from the portfolio through hedging (Strategic Growth Fund) or reduction in the average maturity of bond holdings (Strategic Total Return Fund). The most defensive position is a fully hedged position in which the entire value of long positions is hedged.
John Hussman Top Holdings of 2026-03-31
View Full List
| Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CORT | Corcept Therapeutics Inc | 126,000 | 5,079.1 | +300.00% | 1.100 | +0.83% | 0.120 | +146.11% | +228.99% | 12,376.2 | Biotechnology | |
UNFI | United Natural Foods Inc | 105,000 | 4,731.3 | -16.67% | 1.020 | -0.17% | 0.170 | +1.62% | +50.97% | 3,076.2 | Retail - Defensive | |
CPB | The Campbell's Co | 210,000 | 4,676.7 | +100.00% | 1.010 | +0.51% | 0.070 | +7.51% | -17.15% | 6,554.6 | Consumer Packaged Goods | |
APA | APA Corp | 105,000 | 4,456.2 | 0% | 0.960 | 0% | 0.030 | -7.73% | +56.15% | 13,191.5 | Oil & Gas | |
ETSY | Etsy Inc | 84,000 | 4,198.3 | 0% | 0.910 | 0% | 0.090 | +26.95% | +47.33% | 7,751.1 | Retail - Cyclical | |
ANIP | ANI Pharmaceuticals Inc | 52,500 | 4,037.3 | +66.67% | 0.870 | +0.35% | 0.230 | -0.26% | +0.38% | 1,801.5 | Drug Manufacturers | |
CNXC | Concentrix Corp | 147,000 | 4,021.9 | +75.00% | 0.870 | +0.37% | 0.240 | +5.08% | -38.41% | 1,502.3 | Software | |
SEZL | Sezzle Inc | 63,000 | 3,987.3 | +20.00% | 0.860 | +0.14% | 0.190 | +94.41% | +143.80% | 5,203.8 | Credit Services | |
ULTA | Ulta Beauty Inc | 7,350 | 3,841.9 | New Holding | 0.830 | +0.83% | 0.020 | -4.59% | -15.24% | 22,046.2 | Retail - Cyclical | |
PSIX | Power Solutions International Inc | 63,000 | 3,835.4 | +100.00% | 0.830 | +0.42% | 0.270 | -62.34% | -51.71% | 636.1 | Industrial Products |
John Hussman's Historical Top Holdings Breakdowns
John Hussman's Top Stock Picks
View Full List
| Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
|---|---|---|---|---|---|---|---|---|---|---|---|
QCOM | Qualcomm Inc | 2026-03-31 | Sold Out Sold Out | -1.13% | 127.07 ($145.96) 182.45 | $147.61 | 1.13% | Sold Out | 0 | -27,300 | |
CHTR | Charter Communications Inc | 2026-03-31 | Sold Out Sold Out | -0.95% | 182.81 ($216.63) 248.19 | $144.98 | -33.07% | Sold Out | 0 | -18,900 | |
G | Genpact Ltd | 2026-03-31 | Sold Out Sold Out | -0.95% | 36.31 ($41.2) 48.24 | $35.17 | -14.64% | Sold Out | 0 | -84,000 | |
CORT | Corcept Therapeutics Inc | 2026-03-31 | Add Add | +0.83% | 32.15 ($37.39) 46.22 | $114.49 | 206.20% | Add 300% | 126,000 | 94,500 | |
ULTA | Ulta Beauty Inc | 2026-03-31 | New Buy New Buy | +0.83% | 510.09 ($636.06) 706.82 | $512.83 | -19.37% | New holding | 7,350 | 7,350 | |
PCRX | Pacira BioSciences Inc | 2026-03-31 | Sold Out Sold Out | -0.79% | 19.16 ($22.22) 26.02 | $26.41 | 18.86% | Sold Out | 0 | -126,000 | |
AEO | American Eagle Outfitters Inc | 2026-03-31 | New Buy New Buy | +0.76% | 16.07 ($22.45) 28.19 | $17.18 | -23.47% | New holding | 210,000 | 210,000 | |
COLL | Collegium Pharmaceutical Inc | 2026-03-31 | New Buy New Buy | +0.75% | 31.99 ($42.34) 48.78 | $35.41 | -16.37% | New holding | 105,000 | 105,000 | |
QGEN | Qiagen NV | 2026-03-31 | New Buy New Buy | +0.73% | 39.07 ($47.48) 55.66 | $41.40 | -12.81% | New holding | 84,000 | 84,000 | |
ALKS | Alkermes PLC | 2026-03-31 | Sold Out Sold Out | -0.71% | 27.2 ($31.02) 35.36 | $48.99 | 57.93% | Sold Out | 0 | -105,000 |
John Hussman Total Holding History ($B)
John Hussman's Asset Allocation
John Hussman Past Portfolios
| Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
|---|---|---|---|---|
Top Ranked Articles
- 1
John Hussman's Hypothetical Growth since 2026-03-31
John Hussman's Yearly Returns
This information is only displayed for Gurus who publicly disclose audited performance records; most hedge funds and private investment firms do not publish such data or only provide limited historical performance information.
| Year | Portfolio % | % | Excess Gain % |
|---|
John Hussman's Holdings Heat Map
Size field: